GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lee's Pharmaceutical Holdings Ltd (OTCPK:LPCUF) » Definitions » Institutional Ownership

LPCUF (Lee's Pharmaceutical Holdings) Institutional Ownership : 1.23% (As of Dec. 12, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Lee's Pharmaceutical Holdings Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Lee's Pharmaceutical Holdings's institutional ownership is 1.23%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Lee's Pharmaceutical Holdings's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Lee's Pharmaceutical Holdings's Float Percentage Of Total Shares Outstanding is 0.00%.


Lee's Pharmaceutical Holdings Institutional Ownership Historical Data

The historical data trend for Lee's Pharmaceutical Holdings's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lee's Pharmaceutical Holdings Institutional Ownership Chart

Lee's Pharmaceutical Holdings Historical Data

The historical data trend for Lee's Pharmaceutical Holdings can be seen below:

2024-02-29 2024-03-31 2024-04-30 2024-05-31 2024-06-30 2024-07-31 2024-08-31 2024-09-30 2024-10-31 2024-11-30
Institutional Ownership 1.24 1.24 1.23 1.23 1.20 0.99 0.90 0.88 0.88 0.88

Lee's Pharmaceutical Holdings Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Lee's Pharmaceutical Holdings Business Description

Traded in Other Exchanges
Address
Hong Kong Science Park, 1st Floor, Building 20E, Phase 3, Shatin, Hong Kong, HKG
Lee's Pharmaceutical Holdings Ltd is a research-driven and market-oriented biopharmaceutical company. Along with its subsidiaries, it develops, manufactures, sells, and markets pharmaceutical products. It focuses on cardiovascular, women's health, pediatrics, rare diseases, oncology, dermatology, and obstetrics. The company's reportable segments are; Proprietary and generic products which generates key revenue, and Licensed-in products. The Proprietary Products portfolio includes Livaracine, Yallaferon, Slounase, and Nadroparin Calcium Injection. Its Licensed-in Products include Centraxal Plus, Dicoflor, Ferplex, and Natulan among others. Geographically, the company generates a majority of its revenue from the People's Republic of China.

Lee's Pharmaceutical Holdings Headlines

No Headlines